Hubert, C., Mitchell, K., Sprowls, S., Shakya, S., Arora, S., Silver, D. J., . . . Rich, J. N. (2023). 361 WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma. Journal of Clinical & Translational Science, 7, 107. https://doi.org/10.1017/cts.2023.401
Chicago Style (17th ed.) CitationHubert, Christopher, et al. "361 WDR5 Represents a Therapeutically Exploitable Target for Cancer Stem Cells in Glioblastoma." Journal of Clinical & Translational Science 7 (2023): 107. https://doi.org/10.1017/cts.2023.401.
MLA (9th ed.) CitationHubert, Christopher, et al. "361 WDR5 Represents a Therapeutically Exploitable Target for Cancer Stem Cells in Glioblastoma." Journal of Clinical & Translational Science, vol. 7, 2023, p. 107, https://doi.org/10.1017/cts.2023.401.